Operating profit increased by 15% in the first quarter of 2010 Sales growth driven by modern insulins and Victoza®
- Sales increased by 9% in Danish kroner and by 11% in local currencies.
o Sales of modern insulins increased by 17% (20% in local currencies).
http://digg.com/u1UZrd
No comments:
Post a Comment